Efficacy and Safety Study of Moxidectin in Adults With Scabies
NCT05875441
Ectoparasitic Infestations, Infections
Los Angeles, California, United States
View Trial DetailsNCT Number: NCT02254564
The main objective of this study is to identify unique DNA sequences within the genome of human scabies that can be utilized to identify the parasite through PCR.
Looking for future studies?
Notify MeAll sexes
Observational
Seton Family of Hospitals- Dell Children's Medical Center of Central Texas and Specially for Children, Austin, Texas, United States
The main objective of this proposed study is to identify unique DNA sequences within the genome of human scabies that can be utilized to identify the parasite through polymerase chain reaction or PCR. The goal of the project is to design an assay that can distinguish samples from skin scrapings containing scabies mites, eggs, or fecal material confirmed by clinic based microscopic evaluation (gold standard) from negative controls (i.e. scrapings for tinea and/or demodex folliculitis) that do not contain Sarcoptes scabiei. We hypothesize that specifically amplifying the unique regions of the Scabies genome using PCR can serve as a means to diagnosis infestations in humans. To address this question, we will optimize PCR amplification of known scabies samples then apply our procedure to DNA extracted from patient samples.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
Seton Healthcare Family
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05875441
Ectoparasitic Infestations, Infections
Los Angeles, California, United States
View Trial DetailsNCT07305961
Ectoparasitic Infestations, Infections
Asti, AT, Italy
View Trial DetailsNCT06404333
Ectoparasitic Infestations, Infections
Manaus, Brazil
View Trial DetailsNCT04332068
Ectoparasitic Infestations, Infections
Manaus, Brazil
View Trial Details